Bio-Rad Laboratories (BIO) Change in Cash (2009 - 2026)

Bio-Rad Laboratories (BIO) has reported Change in Cash for 18 consecutive years, with $9.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Change in Cash rose 106.47% year-over-year to $9.8 million in Q2 2026; TTM through Jun 2026 was $147.1 million, a 508.61% increase from a year earlier, with the FY2025 full-year figure at $42.4 million, down 50.35% from the prior year.
• Change in Cash was $9.8 million for Q2 2026 at Bio-Rad Laboratories, up from -$23.2 million in the prior quarter.
• Over five years, Change in Cash peaked at $331.5 million in Q1 2022 and troughed at -$205.7 million in Q2 2022.
• A 5-year average of $2.6 million and a median of $7.2 million in 2024 frame the typical range for Change in Cash.
• Across the five-year window, Change in Cash jumped 3030.82% in 2022 and sank 480.08% in 2025, its largest moves.
• Over 5 years, Change in Cash stood at -$83.7 million in 2022, then surged by 35.65% to -$53.9 million in 2023, then jumped by 244.05% to $77.6 million in 2024, then surged by 72.68% to $134.0 million in 2025, then slumped by 92.69% to $9.8 million in 2026.
• The last three Change in Cash figures came in at $9.8 million (Q2 2026), -$23.2 million (Q1 2026), and $134.0 million (Q4 2025), per Business Quant data.